Comera Life Sciences Holdings- Warrants (19/05/2027) Profit Margin

As of the most recent data (September 2023), CMRAW shows a profit margin of -8421.91%. That compares with -4205.98% in the prior-year period — down 100.2% year over year. That is below the sector sector average of 13.23%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CMRAW's profit margin is now -8421.91% (was -4205.98%) — a 100.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Comera Life Sciences Holdings- Warrants (19/05/2027) is outperforming or lagging.

The its sector sector average profit margin is about 13.23%. Comera Life Sciences Holdings- Warrants (19/05/2027) is at -8421.91%, which is lower that average. That is roughly 63776.2% below the sector mean. Use the comparison chart on this page to see how CMRAW stacks up against individual peers as well.

That compares with -4205.98% in the prior-year period — down 100.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Comera Life Sciences Holdings- Warrants (19/05/2027) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Comera Life Sciences Holdings- Warrants (19/05/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -8421.91%) with ownership activity and broader fundamentals.